Provided by Tiger Trade Technology Pte. Ltd.

Bicara Therapeutics

21.68
+0.84004.03%
Post-market: 21.680.00000.00%16:10 EDT
Volume:365.78K
Turnover:7.88M
Market Cap:1.42B
PE:-7.75
High:21.96
Open:20.84
Low:20.54
Close:20.84
52wk High:24.25
52wk Low:7.80
Shares:65.47M
Float Shares:47.99M
Volume Ratio:0.78
T/O Rate:0.76%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.7971
EPS(LYR):-2.5230
ROE:-32.34%
ROA:-21.09%
PB:2.76
PE(LYR):-8.59

Loading ...

Company Profile

Company Name:
Bicara Therapeutics
Exchange:
NASDAQ
Establishment Date:
2018
Employees:
103
Office Location:
116 Huntington Avenue,Suite 703,Boston,Massachusetts,United States
Zip Code:
02116
Fax:
- -
Introduction:
- -

Directors

Name
Position
Claire Mazumdar
Chief Executive Officer and Director
Michael Powell
Chairperson of the Board
Ryan Cohlhepp, Pharm.D
President, Chief Operating Officer and Director
Carolyn Ng
Director
Christopher Bowden
Director
Heath Lukatch
Director
Jake Simson
Director
Kate Haviland
Director
Kiran Mazumdar Shaw
Director
Nils Lonberg
Director
Scott Robertson
Director
Vijay Kuchroo, D.V.M
Director

Shareholders

Name
Position
Claire Mazumdar
Chief Executive Officer and Director
Ryan Cohlhepp, Pharm.D
President, Chief Operating Officer and Director
Ivan Hyep
Chief Financial Officer
David Raben
Chief Medical Officer
Lara Meisner
Chief Legal Officer